Navigation Links
Keryx Biopharmaceuticals, Inc. Announces Positive Preliminary Phase 2 Data on KRX-0401 in Patients with Chemo-Insensitive Rare Sarcoma
Date:11/5/2007

Data presented at the 13th Annual Meeting of Connective Tissue Oncology Society held in Seattle, Washington demonstrates clinical activity and

tolerability of perifosine as a single agent in patients with

chemo-insensitive sarcomas

NEW YORK, Nov. 5 /PRNewswire-FirstCall/ -- Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX) today announced that preliminary data demonstrating the tolerability and clinical activity of KRX-0401 (perifosine) in patients with refractory, rare sarcomas was presented on Saturday, November 3, 2007 at the Annual Meeting of the Connective Tissue Oncology Society.

In an oral presentation entitled "A PHASE II TRIAL OF PERIFOSINE IN PATIENTS WITH CHEMO-INSENSITIVE SARCOMAS: PRELIMINARY RESULTS," Dr. Joseph Ludwig Assistant Professor, Dept of Sarcoma, MD Anderson Cancer Center reported on preliminary Phase 2 data in which single agent perifosine demonstrated a 40% overall clinical benefit (Stable Disease > 3 months) in these subsets of patients. Assessment of response was completed by both, RECIST and Choi criteria, and results by sarcoma subtype as follows:

Sarcoma Histology Evaluable PR (Choi) SD > 12 wks

Patients N (%) N (%)

Chondrosarcoma 25 1 (4%) 5 (20%)

Extra-Skeletal Myxoid 13 2 (15%) 5 (38%)

Alveolar Soft Part 10 3 (30%) 3 (30%)

TOTAL 48 6 (13%) 13 (27%)

Perifosine was also well tolerated with the most common grade 1 & 2 adverse events reported as nausea, vomiting, diarrhea and fatigue.

C
'/>"/>

SOURCE Keryx Biopharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Keryx Biopharmaceuticals to Present at William Blair & Company Small-Cap Growth Stock Conference
2. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
3. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
4. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
5. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
6. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
7. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
8. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
9. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
10. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
11. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... According to a new market ... Trends & Forecasts (2015-2020) , published by Mordor Intelligence, ... 2.85 billion by the end of 2020, with ... globally accounting for more than 36% of the global ... expected to grow at a CAGR of 44.6% during ...
(Date:7/28/2015)... , July 28, 2015  Insulet Corporation (NASDAQ: ... with its OmniPod ® Insulin Management System, today ... appointed to Insulet,s Board of Directors. Dr. ... experience to the Insulet Board. She currently serves as ... Diabetes Center, the world,s largest diabetes research center, diabetes ...
(Date:7/28/2015)... 28, 2015   Regulus Therapeutics Inc . ( ... and development of innovative medicines targeting microRNAs, today announced ... the quarter ended June 30, 2015 on Tuesday, August ... Regulus will host a conference call and ... Eastern Daylight Time to discuss its second quarter 2015 ...
Breaking Medicine Technology:New Approaches and Technical Advances by Major Players Like Novartis, Merck KGaA, Pfizer, GlaxoSmithKline and Others to Elevate the Global Therapeutic Vaccines Market 2New Approaches and Technical Advances by Major Players Like Novartis, Merck KGaA, Pfizer, GlaxoSmithKline and Others to Elevate the Global Therapeutic Vaccines Market 3Insulet Appoints Jessica Hopfield, PhD, to Board of Directors 2Insulet Appoints Jessica Hopfield, PhD, to Board of Directors 3Regulus Announces Timing for Second Quarter 2015 Financial Results Webcast and Conference Call 2Regulus Announces Timing for Second Quarter 2015 Financial Results Webcast and Conference Call 3
(Date:7/29/2015)... ... 2015 , ... HealthPostures ( https://healthpostures.com ), a sit stand ... ergonomics specialty firm. Purpose of the partnership is to help strengthen and expand ... worker mobility, functionality and fitness levels. , Executives at HealthPostures and 247Ergo ...
(Date:7/29/2015)... ... July 29, 2015 , ... EndoMune ... a chewable version of its EndoMune Jr. probiotic supplement for children ages 3-8. ... that children can enjoy to maintain a healthy balance of beneficial gut bacteria,” ...
(Date:7/28/2015)... (PRWEB) , ... July 29, 2015 , ... ... C-Level executives, doctors, lawyers and other A-Listers, has evolved into a world class ... Meet a Millionaire strives to match successful and attractive people seeking real, meaningful ...
(Date:7/28/2015)... ... July 29, 2015 , ... The insurance telematics or ... This would allow insurers to access the on-board vehicle data and better understand customer ... it comes to sharing vehicle data. However times are changing and automakers realize that ...
(Date:7/28/2015)... (PRWEB) , ... July 28, 2015 , ... Santa Rosa’s The Press Democrat announced its ... a row, Dr. Francisco Canales and Dr. Heather Furnas took the top spot as the ... Dr. Furnas and Dr. Canales are proud to be bestowed such a prestigious title. ...
Breaking Medicine News(10 mins):Health News:HealthPostures and 247Ergo Partnership Strengthens America's Wellness 2Health News:HealthPostures and 247Ergo Partnership Strengthens America's Wellness 3Health News:EndoMune Advanced Probiotic adds Chewable Tablet for Kids to Product Line 2Health News:EndoMune Advanced Probiotic adds Chewable Tablet for Kids to Product Line 3Health News:Meet a Millionaire Announces It’s Not a Sugar Daddy Site, It’s a True Millionaires Club 2Health News:General Motors Engaging Insurance Partners for the Connected Car 2Health News:General Motors Engaging Insurance Partners for the Connected Car 3Health News:Dr. Canales and Dr. Furnas Honored as Sonoma County’s Best Cosmetic Surgeons 2
... that might one day be used to block the ... disease. Their experiments offer not an immediate cure, but ... the development of this relentless neurodegenerative disorder. Huntington,s ... mutation in a single gene and marked by progressive ...
... drink warm milk or listen to soothing music, many insomniacs probably ... sleep. Scientists at Washington University School of Medicine in St. ... flies. In a study appearing June 24 in Science, ... the brains of fruit flies controls when and how long the ...
... 23 (HealthDay News) -- Being married improves the likelihood of ... Married men and women with colon cancer were 14 percent ... to U.S. researchers who analyzed 127,753 patient records. The ... stages of colon cancer and sought more aggressive treatment, which ...
... makes a happy meal? Many people ... the contribution this behavior makes to the current obesity ... system circuits that control it. Insight into this could ... curb this potentially detrimental behavior. In this context, a ...
... THURSDAY, June 23 (HealthDay News) -- Cocaine contaminated with levamisole, ... could result in a U.S. public health epidemic, experts warn. ... in an upcoming print issue of the Journal of ... in Los Angeles and New York who smoked or snorted ...
... latest works by some of Singapore,s leading writers and ... spotlight at The Contemporary, an international conference of literature ... (NTU). Presented by the University,s Division ... Social Sciences (CLASS) programme, The Contemporary conference will feature ...
Cached Medicine News:Health News:A step toward controlling Huntington's disease? 2Health News:A step toward controlling Huntington's disease? 3Health News:Sleep switch found in fruit flies 2Health News:JCI table of contents: June 23, 2011 2Health News:JCI table of contents: June 23, 2011 3Health News:JCI table of contents: June 23, 2011 4Health News:JCI table of contents: June 23, 2011 5Health News:JCI table of contents: June 23, 2011 6Health News:JCI table of contents: June 23, 2011 7Health News:Tainted Cocaine Tied to Severe Skin Reactions 2Health News:NTU hosts landmark conference on contemporary literature and the arts 2
1.0% Casein digest (NZ amine), 0.5% Sodium Chloride....
0.5% Yeast Extract, 2.0% Tryp, 10mM Sodium Chloride, 2.5mM Potassium Chloride, 10mM Magnesium Chloride, 10mM Mag. Sulfate....
S.O.C. Medium...
3.2% Tryptone, 2.0% Yeast Extract, 0.5% Sodium Chloride, pH 7.5....
Medicine Products: